文献速递重症综合管理与镇静镇痛心脑血管急症

右正中神经电刺激促醒急性创伤性昏迷:一项随机对照试验

Acute traumatic coma awakening by right median nerve electrical stimulation: a randomised controlled trial.
PubMed 文献 · Intensive Care Med · 2023-05-13
一句话结论多中心随机对照试验显示,右正中神经电刺激可提高创伤后急性昏迷患者6个月苏醒比例(72.5% vs 56.8%,p=0.004),但作者认为尚需确证性试验验证。

该研究在中国22个中心纳入创伤性脑损伤后7-14天仍处于急性昏迷的患者,按1:1随机分为常规治疗联合右正中神经电刺激组(20 mA、300 μs、40 Hz,每分钟持续20秒,每天8小时,共2周)与单纯常规治疗组。主要终点为伤后6个月恢复意识的比例,电刺激组72.5%(n=121,95%CI 65.2-78.7%)高于对照组56.8%(n=92,95%CI 49.1-64.2%),p=0.004。电刺激组3个月和6个月GOSE、28天FOUR评分均高于对照组,GCS、CRS-R、DRS改善轨迹更快,两组不良事件相似,无与刺激设备相关的严重不良事件。作者认为右正中神经电刺激可能是急性创伤性昏迷的有效治疗,但需确证性试验验证。

要点

  • 创伤后7-14天仍急性昏迷患者,常规治疗联合右正中神经电刺激2周,6个月苏醒比例72.5%(n=121,95%CI 65.2-78.7%)vs 对照组56.8%(n=92,95%CI 49.1-64.2%),p=0.004。
  • 电刺激参数为20 mA、300 μs、40 Hz,每分钟持续20秒,每天8小时,共2周。
  • 电刺激组6个月GOSE中位数6(IQR 3-7)vs 对照组4(IQR 2-7),p=0.0005;3个月GOSE 5(IQR 3-7)vs 4(IQR 2-6),p=0.002。
  • 电刺激组28天FOUR中位数15(IQR 13-16)vs 对照组13(IQR 11-16),p=0.002;GCS、CRS-R、DRS改善轨迹更快(p=0.01、0.004、0.04)。
  • 两组不良事件相似,无与刺激设备相关的严重不良事件;作者认为该治疗可能有效,但需确证性试验验证。

适用人群与场景

  • 中国22个中心、创伤性脑损伤后7-14天仍处于急性昏迷的患者,随机分为右正中神经电刺激联合常规治疗组或单纯常规治疗组。

处置流程与药物剂量

  • 右正中神经电刺激组在常规治疗基础上接受20 mA、300 μs、40 Hz刺激脉冲,每分钟持续20秒,每天8小时,共2周。

研究设计与关键结果

  • 多中心随机对照试验,中国22个中心,2016年3月26日至2020年10月18日招募329例,右正中神经电刺激组167例、对照组162例,主要分析基于意向性治疗集。
  • 伤后6个月恢复意识比例:电刺激组72.5%(n=121,95%CI 65.2-78.7%)vs 对照组56.8%(n=92,95%CI 49.1-64.2%),p=0.004。
  • 3个月GOSE中位数:电刺激组5(IQR 3-7)vs 对照组4(IQR 2-6),p=0.002;6个月GOSE中位数:电刺激组6(IQR 3-7)vs 对照组4(IQR 2-7),p=0.0005。
  • 28天FOUR中位数:电刺激组15(IQR 13-16)vs 对照组13(IQR 11-16),p=0.002。
  • 轨迹分析显示电刺激组GCS、CRS-R、DRS改善更快的患者显著更多(p分别为0.01、0.004、0.04)。
  • 两组不良事件相似,无与刺激设备相关的严重不良事件。

证据类型、等级与局限

  • 证据类型:随机对照试验(多中心,中国22个中心)。
  • 作者结论:右正中神经电刺激可能是急性创伤性昏迷的有效治疗,需确证性试验验证。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,右正中神经电刺激可能是急性创伤性昏迷的有效治疗,但需确证性试验验证。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Severe traumatic brain injury (TBI) leads to acute coma and may result in prolonged disorder of consciousness (pDOC). We aimed to determine whether right median nerve electrical stimulation is a safe and effective treatment for accelerating emergence from coma after TBI.

METHODS: This randomised controlled trial was performed in 22 centres in China. Participants with acute coma at 7-14 days after TBI were randomly assigned (1:1) to either routine therapy and right median nerve electrical stimulation (RMNS group) or routine treatment (control group). The RMNS group received 20 mA, 300 μs, 40 Hz stimulation pulses, lasting 20 s per minutes, 8 h per day, for 2 weeks. The primary outcome was the proportion of patients who regained consciousness 6 months post-injury. The secondary endpoints were Glasgow Coma Scale (GCS), Full Outline of Unresponsiveness scale (FOUR), Coma Recovery Scale-Revised (CRS-R), Disability Rating Scale (DRS) and Glasgow Outcome Scale Extended (GOSE) scores reported as medians on day 28, 3 months and 6 months after injury, and GCS and FOUR scores on day 1 and day 7 during stimulation. Primary analyses were based on the intention-to-treat set.

RESULTS: Between March 26, 2016, and October 18, 2020, 329 participants were recruited, of whom 167 were randomised to the RMNS group and 162 to the control group. At 6 months post-injury, a higher proportion of patients in the RMNS group regained consciousness compared with the control group (72.5%, n = 121, 95% confidence interval (CI) 65.2-78.7% vs. 56.8%, n = 92, 95% CI 49.1-64.2%, p = 0.004). GOSE at 3 months and 6 months (5 [interquartile range (IQR) 3-7] vs. 4 [IQR 2-6], p = 0.002; 6 [IQR 3-7] vs. 4 [IQR 2-7], p = 0.0005) and FOUR at 28 days (15 [IQR 13-16] vs. 13 [interquartile range (IQR) 11-16], p = 0.002) were significantly increased in the RMNS group compared with the control group. Trajectory analysis showed that significantly more patients in the RMNS group had faster GCS, CRS-R and DRS improvement (p = 0.01, 0.004 and 0.04, respectively). Adverse events were similar in both groups. No serious adverse events were associated with the stimulation device.

CONCLUSION: Right median nerve electrical stimulation is a possible effective treatment for patients with acute traumatic coma, that will require validation in a confirmatory trial.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Wu X, Xie L, Lei J, et al. Acute traumatic coma awakening by right median nerve electrical stimulation: a randomised controlled trial. Intensive Care Med. 2023. PMID: 37178149. doi:10.1007/s00134-023-07072-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。